- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Business Development Office
- Partnering opportunities
- A complete cure for HBV
- A stable efficacious Toxoplasma vaccine
- Activating SMCHD1 to treat FSHD
- Improving vision outcomes in retinal detachment
- Intercepting inflammation with RIPK2 inhibitors
- Novel inhibitors for the treatment of lupus
- Novel malaria vaccine
- Novel mucolytics for the treatment of respiratory diseases
- Precision epigenetics silencing SMCHD1 to treat Prader Willi Syndrome
- Rethinking CD52 a therapy for autoimmune disease
- Targeting minor class splicing
- Partnerships and collaborations
- Royalties distribution
- Start-up companies
- Collaborators
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- People
- Anne-Laure Puaux
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Alyssa Barry
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Emma Josefsson
- Associate Professor Ethan Goddard-Borger
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Murphy
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Leanne Robinson
- Associate Professor Marco Herold Marco Herold
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Sant-Rayn Pasricha
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Wai-Hong Tham
- Associate Professor Wei Shi
- Catherine Parker
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gemma Kelly
- Dr Gwo Yaw Ho
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Joanna Groom
- Dr John Wentworth
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Melissa Call
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Samir Taoudi
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Simon Chatfield
- Dr Tracy Putoczki
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Joel Chibert
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Gabrielle Belz
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Burgess
- Professor Tony Papenfuss
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Undergraduate
- Student research projects
- A new regulator of stemness to create dendritic cell factories for immunotherapy
- Advanced methods for genomic rearrangement detection
- Control of cytokine signaling by SOCS1
- Defining the protein modifications associated with respiratory disease
- Delineating the pathways driving cancer development and therapy resistance
- Developing a new drug that targets plasmacytoid dendritic cells for the treatment of lupus
- Development and mechanism of action of novel antimalarials
- Development of a novel particle-based malaria vaccine
- Development of tau-specific therapeutic and diagnostic antibodies
- Discovering novel therapies for major human pathogens
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Epigenetic biomarkers of tuberculosis infection
- Essential role of glycobiology in malaria parasites
- Evolution of haematopoiesis in vertebrates
- Human lung protective immunity to tuberculosis
- Identifying novel treatment options for ovarian carcinosarcoma
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of mutant p53 in cancer
- Microbiome strain-level analysis using long read sequencing
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Modelling spatial and demographic heterogeneity of malaria transmission risk
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Structural basis of catenin-independent Wnt signalling
- Structure and biology of proteins essential for Toxoplasma parasite invasion
- T lymphocytes: how memories are made
- TICKER: A cell history recorder for longitudinal patient monitoring
- Targeting host pathways to develop new broad-spectrum antiviral drugs
- Targeting post-translational modifications to disrupting the function of secreted proteins
- Targeting the epigenome to rewire pro-allergic T cells
- Targeting the immune microenvironment to treat KRAS-mutant adenocarcinoma
- The E3 ubiquitin ligase Parkin and mitophagy in Parkinson’s disease
- The molecular controls on dendritic cell development
- Understanding malaria infection dynamics
- Understanding the genetics of neutrophil maturation
- Understanding the neuroimmune regulation of innate immunity
- Understanding the proteins that regulate programmed cell death at the molecular level
- Using cutting-edge single cell tools to understand the origins of cancer
- When healthy cells turn bad: how immune responses can transition to lymphoma
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Board

The Institute board governs the Institute, manages policy and provides strategic direction.
Key documents
Mrs Jane Hemstritch
BSc (Hons) London University FICAEW FICAA FAICD Mrs Hemstritch was managing director Asia Pacific for Accenture Limited from 2004 until her retirement in February 2007. In this role, Mrs Hemstritch was a member of Accenture’s global executive leadership team and oversaw the management of Accenture’s business portfolio in Asia Pacific. She holds a Bachelor of Science with Honours in biochemistry and physiology and has professional expertise in technology, communications, change management and accounting. Mrs Hemstritch is a member of the Global Council of Herbert Smith Freehills, the Council of Governing Members of The Smith Family and Chief Executive Women. She is an independent non-executive director of Lend Lease Corporation Limited and is Chair of the Accenture Australia Foundation. |
|
Mr Terry Moran AC
BA (Hons) LaTrobe Doctors of Letters (honoris causa) Latrobe Mr Terry Moran is the former secretary of the Department of Prime Minister and Cabinet. Prior to that, he was secretary of the Victorian Department of Premier and Cabinet and CEO of three major educational institutions. Mr Moran’s involvement in the public service has resulted in the establishment of institutions that have made important contributions to Australia’s cultural and educational landscape, such as the Wheeler Centre, the Grattan Institute, Opera Victoria, the Melbourne Recital Centre, and the Australian and New Zealand School of Government. He is Chancellor of Federation University, Chair of the Centre for Policy Development and a Director of the Menzies Foundation. |
|
Mr Robert Wylie
FCA FAICD Mr Wylie is a fellow of the Australian Institute of Company Directors, a fellow and past president of the Institute of Chartered Accountants in Australia and a member of the Institute of Chartered Accountants in Scotland. He is a non-executive director of Maxitrans Industries Limited. Mr Wylie joined Deloitte in 1973 in the United Kingdom, transferring to Australia in 1976. He was National Chairman of Deloitte Australia from 1993 to 2001. He was Deputy Managing Partner Asia Pacific from 2001 before joining Deloitte & Touche USA as a senior executive partner in 2002 until 2006. He was also a member of The Deloitte Global Board and Global Governance Committee as well as The Deloitte Consulting Global Board. |
|
Mr Malcolm Broomhead AO
BE (Civil) MBA UQ FIE (Aus) FAusIMM FAIM MICE (UK), FAICD Mr Broomhead is a professional non-executive director. His directorships include BHP Group Limited & Plc and Orica Limited (Chairman) and he is a council member of Opportunity International Australia. Mr Broomhead was formerly managing director and CEO of Orica Limited from 2001 until September 2005. Prior to Orica, he was Managing Director and CEO of the global diversified resources company North Limited. He has had extensive experience in the resources industry, as well as in finance, investment and construction activities. He has worked in management positions with Halcrow (UK), MIM Holdings, Peko Wallsend and Industrial Equity. |
|
Mr Peter Collins
BA (Hons) Melbourne BTheology MCD Masters Oxford and HEC Paris Mr Collins is the Director of the Vincent Fairfax Fellowship in Ethics. He consults on ethics and leadership with ASX100 companies, Australian and Victorian Government departments and the health and medical research sector. Mr Collins started his consulting career at McKinsey & Company with a focus on organisational change and leadership. Prior to this he worked in the Australian Parliament, for the Minister for Foreign Affairs and later the Minister for Health. Mr Collins has a Masters degree from the University of Oxford and HEC Paris and is undertaking a Doctor of Philosophy in ethics at the University of Oxford. |
|
Associate Professor (Practice) Pippa Connolly
MEng Leeds GAICD CPEng FIEAust Associate Professor Pippa Connolly is a non-executive director at the Royal Melbourne Hospital. Her previous board experience includes positions with the State Board of Arup and the National Association of Women in Construction. Associate Professor Connolly has a background as a senior executive building engineer, delivering multiple-disciplinary major infrastructure projects including the National Museum of Australia, the Museum of New Zealand Te Papa Tongarewa (Te Papa), Olympic Dam infrastructure and the expansion of the Walter and Eliza Hall Institute. Much of her experience has been gained as a director/principal of Arup in the UK, USA, Singapore, New Zealand and Australia. She holds a Masters in Architectural Engineering and is an Associate Professor at Monash University where she lectures and coordinates the Capstone Unit in Civil and Environmental Engineering practice and mentors two industry intern programs for Monash University. |
|
Mr John Dyson
BSc Monash Grad Dip Fin Inv SIA MBA RMIT Mr Dyson has been an active participant in the venture capital industry for two decades. He is one of the founders of Starfish Ventures, a venture capital company established in 2001; and former chair of Swinburne Ventures Pty Ltd, the entity responsible for the commercialisation of technology for Swinburne University of Technology. From 1997 to 2002 he was a director of the Australian Venture Capital Association Limited, including Deputy Chairman in 1998 and Chairman in 1999. He is currently a director of technology companies Aktana, Atmail, Audinate, Design Crowd, Echoview, Hearables 3D and Nitro Software. Mr Dyson is a former Chairman of the Mount Buller and Mount Stirling Alpine Resort Management Board, which oversees the management of Victoria’s largest alpine resort. He is also a co-trustee of the Dyson Bequest, a $15 million charitable foundation that supports a range of social welfare, education, medical research and environmental causes. |
|
Professor Shitij Kapur
MBBS AIIMS PhD Toronto FRCPC FMedSci Professor Shitij Kapur is the Dean, Faculty of Medicine, Dentistry and Health Sciences and assistant Vice-Chancellor (Health), University of Melbourne. Professor Kapur is a clinician-scientist with expertise in psychiatry, neuroscience and brain imaging. Before moving to Australia, he was Executive Dean of the Institute of Psychiatry, Psychology and Neuroscience, Europe's largest and leading centre for mental health research. He has served as a non-executive director of the South London and Maudsley NHS Trust in the UK, as Secretary of the International College of the Neuropsychopharmacology, and Treasurer of the Schizophrenia International Research Society. He currently serves as a director on the boards of Melbourne Health, St Vincent’s Institute for Medical Research, Aikenhead Centre for Medical Discoveries and chairs the board of the Melbourne Academic Centre for Health. |
|
Professor Christine Kilpatrick AO
MBBS MBA MD DMedSci (Hons) Melbourne FRACP FRACMA FAICD FAHMS Professor Kilpatrick commenced as Chief Executive, Melbourne Health in May 2017. Previous appointments include Chief Executive, the Royal Children’s Hospital (2008-17), executive director medical services, Melbourne Health and executive director Royal Melbourne Hospital, Melbourne Health (2004-08). Prior to these appointments she was a neurologist, specialising in epilepsy. Professor Kilpatrick is a member of boards including Orygen, National Centre of Excellence in Youth Mental Health, and the Victorian Comprehensive Cancer Centre. She was awarded a Centenary Medal in 2003, in 2014 was included in the Victorian Honour Roll of Women, in 2017 was a recipient of the inaugural Distinguished Fellow’s Award, Royal Australasian College of Medical Administrators, in 2018 was inducted in the Top 50 Public Sector Women and in 2019 appointed an Officer of the Order of Australia. |
|
Professor James McCluskey AO
BMedSc MBBS MD UWA FRACP FRCPA FAA FAHMS Professor McCluskey is Deputy Vice-Chancellor (Research) at The University of Melbourne and a Redmond Barry Distinguished Professor in Microbiology and Immunology. He has published widely on the genetic control of specific immunity and his research has been recognised by a number of awards. Professor McCluskey is a director of Australian Friends of Asha Slums, the Victorian Comprehensive Cancer Centre, UoM Commercial, Trinity College, the Chair of Nossal Institute Ltd and a foundation director of the governing board of the Atlantic Institute, Oxford. He is a consultant to the Australian Red Cross Blood Service Immunogenetics and Transplantation Services. He has previously been a board director of the Bionics Institute, the Florey Institute of Neuroscience and Mental Health, the Burnet Institute and St Vincent’s Institute. Professor McCluskey led the development of the Peter Doherty Institute for Infection and Immunity, and also led the multi-institutional team that developed the Atlantic Fellows Social Equity Program supported by The Atlantic Philanthropies. |
|
Ms Marie McDonald
BSc (Hons) LLB (Hons) Melbourne Ms McDonald was a partner of Blake Dawson (now global law firm Ashurst) from 1990 to 2014. She specialised in corporate and commercial law and, in particular, cross-border mergers and acquisitions and corporate governance. She was a member of the Australian Takeovers Panel (2001-2010) and Chair of the Corporations Committee of the Business Law Section of the Law Council of Australia (2012, 2013) and a Deputy Chair (2010, 2011). Prior to becoming a lawyer, Ms McDonald completed a Bachelor of Science (Honours) degree with first class honours, majoring in chemistry. Ms McDonald is a non-executive director of CSL Limited, Nanosonics Limited and Nufarm Limited. She is also a senior adviser at Flagstaff Partners, a corporate advisory firm. |
|
Professor Sir John Savill
BA Oxford MBChB Sheffield PhD London FRCP FRCPE FRCSEd (Hon) FRCPCH(Hon) FASN FRSE FMedSci FRS Professor Sir John is the executive director of the Melbourne Academic Centre for Health (July 2019-present) after having served as an honorary consultant in renal and acute medicine in the UK (1990-2018). In 2000 he established the Medical Research Council (MRC) Centre for Inflammation Research in Edinburgh as inaugural director. Professor Sir John served as Vice-Principal and Head of the College of Medicine and Veterinary Medicine at the University of Edinburgh (2002-17) and was appointed to the Regius Chair of Medical Science in 2017. He was Chief Scientist in the Scottish Government Health Directorates (2008-10) and Chief Executive of the UK Medical Research Council (2010-18), having previously served as a member of MRC Council and research board chair (2002-08). Professor Sir John’s work has been recognised by fellowships of the Royal Colleges of Physicians of London and Edinburgh, the Academy of Medical Sciences, the American Society of Nephrology, The Royal Society of Edinburgh, The Royal Society and honorary fellowships from the Royal College of Surgeons of Edinburgh and the Royal College of Paediatrics and Child Health. He was knighted in the 2008 New Year’s Honours List for services to clinical science.
|
|
Ms Carolyn Viney
LLB/BA Monash Ms Carolyn Viney has more than 20 years’ experience in construction, property development and real estate investment. Ms Viney is currently the Chief Development Officer at Vicinity Centres. Over a 13-year period she held a number of senior roles at Grocon, including CEO, Deputy CEO, Head of Development and in-house counsel. Before this, she was a senior associate at law firm Minter Ellison. Ms Viney is an advisory board member to the Victorian Government’s Office of Projects Victoria, an advisory board member of Women’s Property Initiatives, a not-for-profit housing provider to women and children at risk of homelessness. She is a non-executive director of The Big Issue and Homes for Homes, both of which are not-for-profit providers of employment and support to homeless, marginalised and disadvantaged people. Ms Viney is a former president of the Victorian Division of the Property Council of Australia. |